Cevex

Quick links to important sections

Cevex

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cevex

Property Description
Active Ingredient L-Ascorbic Acid (Vitamin C)
Form Tablet, chewable tablet, injectable solution
Pharmacological Class Water-soluble vitamin, Antioxidant
Common Use Prevention and treatment of deficiency (e.g., scurvy)
Origin Synthetic

Cevex is a pharmaceutical preparation primarily classified as an essential nutrient and a water-soluble vitamin indicated for maintaining the body's required level of Ascorbic acid. This single-ingredient product is typically categorized as Over-the-Counter (OTC), reflecting its importance in general nutritional health maintenance.


What Pharmacological Class Does Cevex Belong To?

Cevex belongs to the pharmacological class of vitamin preparations, specifically the water-soluble vitamin group. The L-ascorbic acid component is clinically recognized for its essential role in human nutrition, as the body cannot synthesize it naturally. This classification dictates that the compound, unlike fat-soluble compounds, is rapidly utilized, and non-retained excess is excreted. The product is often differentiated by its range of dosage forms, including convenient chewable tablets alongside standard oral tablets and specialized injectable solution preparations.


Cevex Composition: Understanding L-Ascorbic Acid

The sole active ingredient in Cevex is L-ascorbic acid, which is chemically identical to Vitamin C (C6H8O6). This compound is primarily a high-purity synthetic substance when produced for commercial pharmaceutical use, ensuring standardized potency. The availability of formulations containing the neutral salt Sodium ascorbate, particularly in aqueous forms, offers a differentiated approach by delivering the active molecule with reduced acidity compared to the pure acid form.


What is the General Purpose of Taking Cevex?

The general purpose of Cevex is to serve as an enzyme co-factor and a potent antioxidant, supporting numerous crucial metabolic and structural functions. The necessity of L-ascorbic acid for the production of collagen, a vital structural protein, is recognized. This function enables the drug's overarching benefit: ensuring essential tissue integrity and preventing severe deficiency, such as scurvy, thereby supporting normal physiological resilience.

Regulatory References

  1. MedlinePlus Vitamin C Function

What side effects are possible with Cevex?

Possible Side Effects and Safety Information

The officially documented safety profile for L-Ascorbic Acid (Cevex) distinguishes between common effects related to dose and serious risks confined to specific patient populations. The most frequently documented reactions, such as diarrhoea, nausea, vomiting, stomach cramps, and headache, are typically associated with the ingestion of large doses.

Adverse effects are documented across several body systems, including Gastrointestinal Disorders, Nervous System Disorders, and Renal and Urinary Disorders. For the injectable preparation, pain and swelling at the infusion site are commonly reported.

Serious adverse reactions are explicitly documented in regulatory materials, primarily linked to pre-existing conditions. These include the risk of oxalate nephropathy (a form of kidney damage) and the formation of renal oxalate calculi (kidney stones), particularly with prolonged, high-dose use in susceptible individuals. A critical safety consideration is the risk of severe haemolysis (red blood cell destruction) in patients with a diagnosed Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.

Safety Consideration Regulatory Note
Population Risk Risk of oxalate nephropathy is heightened in patients with renal impairment or a history of oxalate kidney stones.
Diagnostic Interference L-Ascorbic Acid may interfere with laboratory tests, potentially causing false results for urinary glucose and faecal occult blood tests.
Dose Pattern Temporary faintness or dizziness may be caused by too-rapid intravenous administration.

L-Ascorbic Acid is contraindicated in individuals with known hyperoxaluria or hypersensitivity to the substance. This safety structure emphasizes that risk is conditional upon dosage and the presence of underlying metabolic or renal vulnerabilities.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation on Cevex (L-Ascorbic Acid) overdose describes a range of manifestations and mandates specific emergency actions.

Over-ingestion commonly results in gastrointestinal disturbances, including diarrhea, nausea, vomiting, abdominal cramps, and heartburn. Other documented, non-life-threatening signs can include headache and fatigue.


Severe Outcomes and At-Risk Populations

Massive overdosage carries a risk of severe complications, particularly in specific patient groups:

Outcome Type Manifestations (Documented)
Renal System Oxalate nephropathy, nephrolithiasis (kidney stone formation), and acute renal failure (due to hyperoxaluria).
Hematologic System Oxidative hemolysis and haemolytic anaemia (specifically in patients with Glucose-6-phosphate dehydrogenase [G6PD] deficiency).

Individuals with renal impairment, a history of oxalate kidney stones, or G6PD deficiency are officially documented to be at increased risk of these severe outcomes.


Emergency Regulatory Actions

The official directive is to consult a doctor if more than the recommended dosage is taken. If overdose symptoms such as persistent diarrhea or vomiting occur, the product should be stopped and a healthcare professional consulted. If a severe adverse reaction is experienced, the official requirement is to seek medical attention immediately.

There is no specific antidote known for L-Ascorbic Acid overdose; treatment is limited to symptomatic and general supportive measures.

Therapeutic Uses of Cevex

Cevex (L-Ascorbic Acid) is used to address deficiencies that create noticeable physiological strain and compromise structural integrity. It is commonly used for the therapeutic management and prevention of severe L-Ascorbic Acid deficiency, applicable within clinical settings that involve acute or disruptive symptom patterns, such as scurvy.

The main therapeutic areas where Cevex is applied include treating deficiencies that manifest as bleeding gums, easy bruising, and profound fatigue. It is also considered relevant in conditions marked by increased physiological stress, such as recovery following major surgery or the management of severe burns. In these scenarios, Cevex assists with maintaining functional stability by supporting the processes required for wound healing and structural tissue maintenance.

“It helps address symptom clusters that may become intense or disruptive, providing support that helps ease the overall symptom burden.”

Cevex is also applied in addressing symptoms related to systemic imbalance, particularly in vulnerable patient groups like older adults or those with malabsorption. It is considered relevant in addressing symptoms associated with iron deficiency that may occur with L-Ascorbic Acid deficiency.


Quick Fact: Relief for Fatigue and Bruising

Cevex supports patients during deficiency episodes by easing distress related to generalized fatigue, muscle weakness, and hemorrhagic symptoms, assisting with maintaining functional stability when physical strain is heightened.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Cevex?

Cevex (L-Ascorbic Acid) eligibility is defined by official regulatory documentation, specifying populations who are approved, restricted, or prohibited from using the medicine.

Contraindications (Must Not Use): Use of Cevex is formally contraindicated in patients with a known hypersensitivity to ascorbic acid or its excipients. It is also prohibited for patients with the metabolic condition Hyperoxaluria, due to the risk of renal complications.

Age-Related Eligibility: The medicine is generally approved for use in adults and adolescents (12 years and older). For specific prescription formulations, use is established for children 5 months and older. Use in infants less than 5 months is not established by regulatory labels.

Conditional and Restricted Use: Caution is required for several patient groups. Individuals with renal impairment or a history of kidney stones may be at increased risk, particularly with high-dose or prolonged use. Patients with G6PD deficiency, diabetes, or iron overload must use Cevex only under specific guidance. Pregnant and lactating women must use the product with caution and must not exceed the recommended daily allowance (RDA).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cevex (L-Ascorbic Acid) has officially documented interaction patterns that affect co-administered medicinal products and certain diagnostic procedures. All reported interactions are based strictly on authoritative government regulatory sources.

A formal regulatory restriction classifies the co-administration with Deferoxamine (Desferrioxamine) as contraindicated in patients with existing cardiac failure. For all other instances of co-use with Deferoxamine, L-Ascorbic Acid must not be initiated until after the first month of regular treatment. This combination is also noted to enhance urinary iron excretion.

The compound affects the pharmacokinetics of other drugs, particularly those sensitive to urinary pH. L-Ascorbic Acid may cause a decrease in serum concentration and increased renal excretion of pH-sensitive weak base drugs, such as Amphetamine and Fluphenazine. Furthermore, L-Ascorbic Acid increases the oral absorption of iron.

Conversely, L-Ascorbic Acid's own plasma concentration is documented to decrease when used concomitantly with Oral Contraceptives or with smoking. A clinically significant interaction with the complementary substance Amygdalin is officially documented as potentially causing cyanide toxicity. Patients with renal insufficiency are noted to be at risk with concurrent use of aluminum-containing antacids. Finally, this substance can interfere with laboratory tests based on oxidation-reduction reactions, including diagnostic assays for glucose and bilirubin.

Mechanism of Action

How Cevex Works


Cevex exerts its action by Modulation of Receptor-Mediated Signaling, engaging specific domains to initiate or suppress targeted signaling sequences. This interaction modifies early molecular steps that govern downstream cellular responses, leading to an alteration of systemic physiological parameters via changes in signal transduction.

Simultaneously, Cevex achieves Targeted Pathway Adjustment in systems where heightened activity may escalate. It achieves this by altering the underlying pathway kinetics, directly engaging mechanisms that regulate otherwise dysregulated processes. This action modulates the intensity of heightened physiological responses within the targeted systems.

Furthermore, the drug facilitates the Regulation of Mediator Activity. It affects systems where specific transmitters or signaling mediators dominate by restricting their concentration or limiting their activity at the site of action. This modification, which influences internal feedback regulation within targeted pathways, facilitates altered feedback regulation critical for maintaining pathway homeostasis.

Dosage and Administration Information

How Cevex is Used: Official Administration Guidelines

Cevex (L-Ascorbic Acid) must be used strictly according to the procedures and dose ranges defined in official regulatory documents and national health agency monographs.

Approved Routes and Conditions of Administration

Route of Administration Context of Use (Official Constraint)
Oral (Tablet, Chewable) The preferred and most common route for administration.
Parenteral (IV, IM, SC) Reserved for acute deficiency when oral administration is not possible, insufficient, or in cases of severe malabsorption.

Standard Labeled Dosing Regimens

Official dosing is based on the therapeutic purpose and formulation:

  • Adult Oral Dose: Typically ranges from 100 mg to 500 mg daily.
  • Adult Parenteral Dose: Generally 100 mg to 250 mg once or twice daily, up to 1 g in severe, acute clinical conditions.
  • Frequency: The standard schedule is once daily, though some deficiency treatments may require divided doses.
  • Duration: Treatment typically continues for a minimum of two weeks or until symptoms of deficiency have resolved, as directed by official protocols.

Special Administration Requirements

  1. Preparation (IV): The concentrated injectable solution must be diluted prior to use to ensure it is isotonic.
  2. Infusion Rate: Intravenous doses must be administered as a slow infusion; the rate should not exceed the labeled maximum, such as 33 mg/minute for certain products.
  3. Pediatrics: Specific, lower daily doses (e.g., 50 mg to 100 mg) are required for infants and young children requiring parenteral administration, following established clinical protocols.

These official instructions define the required method and duration of use, ensuring administration aligns with documented regulatory standards.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cevex (L-Ascorbic Acid)

Cevex (L-Ascorbic Acid) has been studied for several clinical purposes, ranging from established deficiency treatment to supportive roles in healing and nutritional processes. The research base includes historical observations, randomized controlled trials (RCTs), and scientific reviews that help contextualize how patients reported their experience and how symptoms evolved in the observed populations.


Research Evidence for Deficiency and Scurvy Treatment

Research has examined L-Ascorbic Acid replacement therapy in patients diagnosed with severe deficiency, historically known as scurvy. Studies focused on outcomes related to systemic imbalance and the symptom evolution of severe, episodic manifestations, such as bleeding gums, profound fatigue, and muscle weakness. The primary goal was to observe the timeline for symptom evolution and changes in biochemical markers (plasma ascorbate levels).

Studies reported patterns related to physiological shifts and the evolution of deficiency symptoms following administration in individuals with confirmed deficiency. Research highlights measurements taken during the study period, noting a rise in the vitamin's levels and observed patterns in the specific symptoms of a confirmed deficiency state. Limited information exists regarding the optimal long-term maintenance approach for all high-risk subgroups.


Evidence on Supportive Use in Wound Healing and Tissue Maintenance

Cevex was also evaluated in research exploring its supportive role in healing processes, particularly in patients recovering from major surgery or severe trauma like severe burns. The studies explored measured outcomes related to healing processes and measures of daily functioning, specifically the rate and quality of wound healing. Some trials reported observations of measured differences in biomarkers related to collagen production between groups receiving L-Ascorbic Acid and control groups.

However, study findings were mixed and highly dependent on the patients’ existing vitamin status and the severity of the trauma or injury. Follow-up durations were limited, and the optimal administration protocol for supportive use in non-deficient surgical or trauma patients remains inconsistent across the research.

Key Studies & References NIH MedlinePlus Drug Information: Ascorbic Acid (Vitamin C)

Frequently Asked Questions (FAQ)

Common questions about Cevex (FAQ)


Q: How quickly am I supposed to feel a difference after starting Cevex?

A: Research evidence related to the treatment of acute deficiency of the substance has examined the timeline for symptom improvement. Studies indicate that while the treatment continues for a minimum duration, the speed at which symptoms evolve or biochemical markers change can vary between individuals.

Q: What happens if I miss a dose of Cevex?

A: Official administration guidelines establish the standard dosing frequency, which is typically once daily. However, specific instructions regarding how to manage or what steps to take for a forgotten dose are generally not included in the regulatory documentation.

Q: Do I need to change my diet while taking Cevex?

A: Official regulatory texts do not mandate a broad diet change when using this product. It is noted that the substance can increase the absorption of iron. Caution is also advised regarding specific interactions, such as with aluminum-containing antacids.

Q: How long does Cevex typically stay in your system after stopping it?

A: Pharmacokinetic data describes the substance as a water-soluble vitamin that is quickly used by the body. Any amounts not retained are typically excreted. The speed at which the substance is eliminated is documented as being highly dependent on the amount administered.

Q: Can I drink alcohol while I am taking Cevex?

A: Regulatory interaction summaries for the L-Ascorbic Acid compound generally do not list a documented interaction with alcohol.

Q: Does Cevex interact with common over-the-counter pain relievers?

A: Official drug information lists specific interactions with certain prescription medications and weak base drugs. However, common general over-the-counter pain relievers, such as ibuprofen or acetaminophen, are not listed in regulatory documents as presenting a documented interaction.

Q: Is it possible to become dependent on Cevex?

A: The substance is classified by essential nutrient fact sheets as a fundamental water-soluble vitamin, which the body cannot synthesize on its own. It is not listed as a controlled substance and official documentation does not indicate a risk of physical or psychological dependence.

Q: Is there any specific time of day that Cevex is supposed to be taken?

A: Official administration guidelines specify that the standard frequency is typically once daily. Regulatory documents do not mandate a specific time of day (e.g., morning versus evening) for the product to be administered.

Q: Can Cevex cause changes in mood or sleep patterns?

A: Changes in mood or fatigue are not listed among the common side effects of appropriate use. However, research documents indicate that fatigue, lethargy, and a decline in vitality are symptoms associated with a confirmed state of deficiency of this substance.

Q: Is Cevex considered a controlled substance?

A: Regulatory agencies do not classify the product (L-Ascorbic Acid), which is an essential water-soluble vitamin preparation, as a controlled substance.

Q: Are the side effects of Cevex temporary?

A: The most frequently documented adverse effects, such as gastrointestinal upset and headache, are typically associated with taking high doses. These reactions are generally considered to be dose-related.

Q: Does Cevex interact with coffee or caffeine?

A: Regulatory summaries of interactions for L-Ascorbic Acid do not list a documented interaction with coffee or caffeine.

Q: Where can I find the official patient information leaflet for Cevex?

A: Official patient information, including drug labels and patient package inserts, is publicly available and searchable on government regulatory websites. These documents can be found on sites such as the FDA’s DailyMed database or the European Medicines Agency (EMA) product information pages.

Q: Does Cevex have a risk evaluation and mitigation strategy (REMS)?

A: The product (L-Ascorbic Acid) is classified as a vitamin preparation and is not listed by the FDA as requiring a specific Risk Evaluation and Mitigation Strategy (REMS) program.

Q: Can taking Cevex make my skin more sensitive to the sun?

A: Regulatory lists of side effects do not include photosensitivity or sun sensitivity as a documented adverse reaction to the substance.

Q: What happens if I accidentally take too much Cevex?

A: Official regulatory documents describe the effects of high-dose ingestion. These are typically dose-related gastrointestinal disturbances, such as nausea and diarrhoea.

Q: Are there any warnings about Cevex and mental health?

A: Official documents do not list general mental health warnings as a side effect. It is noted, however, that a decline in vitality, fatigue, and other mood effects are commonly observed as symptoms in individuals with a confirmed state of deficiency of the substance.

Q: Is it normal to feel [vague common symptom] when first taking Cevex?

A: Official documents list common reactions typically associated with the ingestion of large doses. These frequently documented effects include diarrhea, nausea, vomiting, stomach cramps, and headache.

Q: Can Cevex affect my ability to drive or operate machinery?

A: A potential effect documented in regulatory materials is temporary faintness or dizziness. This is specifically associated with administering the injectable form too rapidly.

Q: Is Cevex safe for older adults or seniors?

A: The medicine is generally approved for use in adults. Official documentation notes that caution is required for individuals, including seniors, who have pre-existing conditions like renal impairment or a history of kidney stones.

Q: Are there any long-term health concerns associated with using Cevex?

A: Prolonged or high-dose use of the substance is documented in official regulatory materials as carrying a risk for certain patient populations. This includes the potential development of renal oxalate calculi (kidney stones) and oxalate nephropathy.

Q: Can people with liver or kidney issues use Cevex?

A: Official documents state that caution is required and potential dose modification may be necessary for individuals with renal (kidney) impairment or a history of oxalate kidney stones. Liver impairment is not listed as a general precaution on the regulatory label.

Q: Does Cevex interact with vitamins or herbal supplements?

A: The official label includes documented interactions that affect iron absorption. It also notes a specific risk when co-administered with the complementary substance Amygdalin.

Q: Are there any specific foods that must be avoided with Cevex?

A: Officially documented interactions do not list specific foods that must be avoided. However, regulatory materials note that the substance increases the oral absorption of iron and that its plasma concentration may decrease with smoking.

Q: Can I take Cevex if I have a history of [specific chronic disease]? (e.g., heart condition)

A: Official documents indicate that caution is required or use may be restricted for patients with conditions such as G6PD deficiency, diabetes, iron overload, renal impairment, and Hyperoxaluria. Official regulatory documents do not generally list other specific chronic diseases, such as heart conditions, as contraindications.

Q: Can Cevex be crushed, cut, or chewed?

A: Official administration guidelines specify that Cevex is available in distinct oral forms, including a chewable tablet and a standard tablet. The approved method of ingestion is defined by the specific formulation being used.

Q: What kind of monitoring is needed while taking Cevex?

A: Regulatory documents note the substance may interfere with laboratory tests based on oxidation-reduction reactions, including diagnostic assays for glucose and bilirubin. This suggests some laboratory tests may require adjustment or careful interpretation during use.

Q: Why do people sometimes stop taking Cevex?

A: Officially documented reasons for discontinuation are generally related to the development of adverse effects, such as diarrhoea or stomach upset. They are also linked to the presence of specific contraindications like Hyperoxaluria.

Q: Does Cevex have an expiration date I need to watch out for?

A: Official storage and disposal sections address the proper handling of "expired" Cevex. This confirms that the product has a limited shelf life determined by the manufacturer.

How should Cevex be stored and disposed of?

How to Store and Dispose of Cevex?

Cevex storage requirements depend on the formulation.

Storage Requirements

Form Temperature & Protection Stability & Handling
Oral Forms Store at controlled room temperature (20 C to 25 C). Keep container tightly closed and protect from moisture. Avoid excessive heat.
Injectable Solution Must be refrigerated (2 C to 8 C) and protected from light. Do not freeze the solution. Use the admixture immediately, or discard any unused portion after the labeled stability period. Discard if discolored or particulate matter is present.

All forms must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Cevex should be disposed of via an official drug take-back program. If this is unavailable, mix the medicine with an undesirable substance (such as used coffee grounds) in a sealed bag before discarding it in the household trash. The product must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cevex found in:

A-Z Index: